These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 29636883
1. The embryonic transcription factor Brachyury confers chordoma chemoresistance via upregulating CA9. Jian J, Zhong N, Jiang D, Li L, Lou Y, Zhou W, Chen S, Xiao J. Am J Transl Res; 2018; 10(3):936-947. PubMed ID: 29636883 [Abstract] [Full Text] [Related]
2. miR-219-5p inhibits proliferation and clonogenicity in chordoma cells and is associated with tumor recurrence. Wei W, Zhang Q, Wang Z, Yan B, Feng Y, Li P. Oncol Lett; 2016 Dec; 12(6):4568-4576. PubMed ID: 28105164 [Abstract] [Full Text] [Related]
3. ZEB1 transcriptionally regulated carbonic anhydrase 9 mediates the chemoresistance of tongue cancer via maintaining intracellular pH. Zheng G, Peng C, Jia X, Gu Y, Zhang Z, Deng Y, Wang C, Li N, Yin J, Liu X, Lu M, Tang H, He Z. Mol Cancer; 2015 Apr 15; 14():84. PubMed ID: 25890268 [Abstract] [Full Text] [Related]
4. Establishment and characterization of a chordoma cell line from the tissue of a patient with dedifferentiated-type chordoma. Kim JY, Lee J, Koh JS, Park MJ, Chang UK. J Neurosurg Spine; 2016 Nov 15; 25(5):626-635. PubMed ID: 27314550 [Abstract] [Full Text] [Related]
5. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma. Otani R, Mukasa A, Shin M, Omata M, Takayanagi S, Tanaka S, Ueki K, Saito N. J Neurosurg; 2018 May 15; 128(5):1428-1437. PubMed ID: 28753115 [Abstract] [Full Text] [Related]
6. Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma. Zhang L, Guo S, Schwab JH, Nielsen GP, Choy E, Ye S, Zhang Z, Mankin H, Hornicek FJ, Duan Z. PLoS One; 2013 May 15; 8(9):e75851. PubMed ID: 24086644 [Abstract] [Full Text] [Related]
7. Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases. Miettinen M, Wang Z, Lasota J, Heery C, Schlom J, Palena C. Am J Surg Pathol; 2015 Oct 15; 39(10):1305-12. PubMed ID: 26099010 [Abstract] [Full Text] [Related]
8. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Tirabosco R, Mangham DC, Rosenberg AE, Vujovic S, Bousdras K, Pizzolitto S, De Maglio G, den Bakker MA, Di Francesco L, Kalil RK, Athanasou NA, O'Donnell P, McCarthy EF, Flanagan AM. Am J Surg Pathol; 2008 Apr 15; 32(4):572-80. PubMed ID: 18301055 [Abstract] [Full Text] [Related]
9. Chordoma: Immunohistochemical Analysis of Brachury. Sun HI, Guduk M, Gucyetmez B, Yapicier O, Pamir MN. Turk Neurosurg; 2018 Apr 15; 28(2):174-178. PubMed ID: 28094431 [Abstract] [Full Text] [Related]
10. Virus-like particle-based delivery of Cas9/guide RNA ribonucleoprotein efficiently edits the brachyury gene and inhibits chordoma growth in vivo. Hu Y, Lu B, Deng Z, Xing F, Hsu W. Discov Oncol; 2023 May 18; 14(1):70. PubMed ID: 37198417 [Abstract] [Full Text] [Related]
11. Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation. O'donnell P, Tirabosco R, Vujovic S, Bartlett W, Briggs TW, Henderson S, Boshoff C, Flanagan AM. Skeletal Radiol; 2007 Jan 18; 36(1):59-65. PubMed ID: 16810540 [Abstract] [Full Text] [Related]
13. Modulation of carbonic anhydrase 9 (CA9) in human brain cancer. Said HM, Supuran CT, Hageman C, Staab A, Polat B, Katzer A, Scozzafava A, Anacker J, Flentje M, Vordermark D. Curr Pharm Des; 2010 Jan 18; 16(29):3288-99. PubMed ID: 20819065 [Abstract] [Full Text] [Related]
14. Recurrent skeletal extra-axial chordoma confirmed with brachyury: imaging features and review of the literature. Lantos JE, Agaram NP, Healey JH, Hwang S. Skeletal Radiol; 2013 Oct 18; 42(10):1451-9. PubMed ID: 23653219 [Abstract] [Full Text] [Related]
15. Development of a Small Molecule Downmodulator for the Transcription Factor Brachyury. Chase DH, Bebenek AM, Nie P, Jaime-Figueroa S, Butrin A, Castro DA, Hines J, Linhares BM, Crews CM. Angew Chem Int Ed Engl; 2024 Apr 02; 63(14):e202316496. PubMed ID: 38348945 [Abstract] [Full Text] [Related]
16. Inhibition Of Glycogen Synthase Kinase 3 Beta Suppresses The Growth And Survival Of Skull Base Chordoma Cells By Downregulating Brachyury Expression. Yan X, Li Z, Li H, Liu P, Zhao Z, Cheng S, Wang Z, Zhang Q. Onco Targets Ther; 2019 Apr 02; 12():9783-9791. PubMed ID: 31819479 [Abstract] [Full Text] [Related]
17. Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy. Koukourakis MI, Giatromanolaki A, Danielidis V, Sivridis E. Int J Radiat Biol; 2008 Jan 02; 84(1):47-52. PubMed ID: 17852557 [Abstract] [Full Text] [Related]
18. The Roles of Embryonic Transcription Factor BRACHYURY in Tumorigenesis and Progression. Chen M, Wu Y, Zhang H, Li S, Zhou J, Shen J. Front Oncol; 2020 Jan 02; 10():961. PubMed ID: 32695672 [Abstract] [Full Text] [Related]
19. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma. Said HM, Hagemann C, Carta F, Katzer A, Polat B, Staab A, Scozzafava A, Anacker J, Vince GH, Flentje M, Supuran CT. Bioorg Med Chem; 2013 Jul 01; 21(13):3949-57. PubMed ID: 23706268 [Abstract] [Full Text] [Related]
20. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining. Rekhi B, Banerjee D, Ramadwar M, Bajpai J, Jambhekar NA. Indian J Pathol Microbiol; 2017 Jul 01; 60(3):350-354. PubMed ID: 28937370 [Abstract] [Full Text] [Related] Page: [Next] [New Search]